EMERGENT BIOSOLUTIONS INC. COMMON STOCK
6.0700
30-July-25 13:30:00
15 minutes delayed
Stocks
-0.4300
-6.62%
Today's range
5.9850 - 6.6400
ISIN
N/A
Source
NYSE
-
28 Jul 2025 05:50:38 By Nasdaq GlobeNewswire
-
Emergent Applauds Availability of Over-the-Counter Naloxone in U.S. House of Representatives
28 Jul 2025 05:50:22 By Nasdaq GlobeNewswire
-
Emergent BioSolutions to Report Second Quarter 2025 Financial Results on August 6, 2025
15 Jul 2025 04:30:16 By Nasdaq GlobeNewswire
-
02 Jul 2025 13:05:19 By Nasdaq GlobeNewswire
-
23 Jun 2025 05:05:07 By Nasdaq GlobeNewswire
-
Emergent BioSolutions Announces Addition to Russell 3000® Index
20 Jun 2025 05:13:29 By Nasdaq GlobeNewswire
-
05 Jun 2025 04:00:21 By Nasdaq GlobeNewswire
-
Emergent BioSolutions to Participate in Upcoming Investor Conferences
14 May 2025 04:32:11 By Nasdaq GlobeNewswire
-
Emergent BioSolutions Reports First Quarter 2025 Financial Results
07 May 2025 13:05:02 By Nasdaq GlobeNewswire
-
01 May 2025 14:07:20 By Nasdaq GlobeNewswire
-
Emergent BioSolutions to Report First Quarter 2025 Financial Results on May 7, 2025
22 Apr 2025 04:59:59 By Nasdaq GlobeNewswire
-
Emergent BioSolutions Announces Stock Repurchase Program
31 Mar 2025 05:00:00 By Nasdaq GlobeNewswire
-
Emergent BioSolutions New Hire Equity Grant Under NYSE Rule 303A.08
20 Mar 2025 13:30:00 By Nasdaq GlobeNewswire
-
Hikma announces Health Canada approval of KLOXXADO® (naloxone HCl) Nasal Spray 8 mg
20 Mar 2025 05:06:17 By Nasdaq GlobeNewswire
-
19 Mar 2025 13:30:00 By Nasdaq GlobeNewswire
-
18 Mar 2025 05:00:00 By Nasdaq GlobeNewswire
-
13 Mar 2025 05:29:43 By Nasdaq GlobeNewswire
-
12 Mar 2025 05:00:26 By Nasdaq GlobeNewswire
-
10 Mar 2025 06:14:36 By Nasdaq GlobeNewswire
- <<
- <
- 1
- >